Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
71.31
+1.78 (2.56%)
At close: May 16, 2025, 4:00 PM
70.00
-1.31 (-1.84%)
After-hours: May 16, 2025, 7:45 PM EDT
Verona Pharma Market Cap
Verona Pharma has a market cap or net worth of $6.50 billion as of May 16, 2025. Its market cap has increased by 420.54% in one year.
Market Cap
6.50B
Enterprise Value
6.34B
1-Year Change
420.54%
Ranking
Category
Stock Price
$71.31
Market Cap Chart
Since April 27, 2017, Verona Pharma's market cap has increased from $173.40M to $6.50B, an increase of 3,648.22%. That is a compound annual growth rate of 56.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 5.92B | 55.76% |
| Dec 31, 2024 | 3.80B | 139.13% |
| Dec 29, 2023 | 1.59B | -19.57% |
| Dec 30, 2022 | 1.98B | 389.96% |
| Dec 31, 2021 | 403.30M | 33.68% |
| Dec 31, 2020 | 301.70M | 298.55% |
| Dec 31, 2019 | 75.70M | -40.25% |
| Dec 31, 2018 | 126.70M | -16.92% |
| Dec 29, 2017 | 152.50M | -12.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |